跳到正文
原文
Novo Nordisk· @novonordisk · X·· 23 小时前精选AI 评分55
AI 导读

诺和诺德公布其一项大型临床试验的新发表结果,78.7%的肥胖儿童在一种诺和诺德药物治疗后BMI至少下降10%,多数儿童转入更低的BMI分级。公司称儿童肥胖持续上升,已影响儿童和家庭的日常生活,详情见其新闻稿。

推荐理由

诺和诺德公布其儿童肥胖试验数据,78.7%的受试儿童BMI至少下降10%,读者可据此了解该药在儿童人群中的减重幅度。

正文

#PRESS Childhood obesity is at the rise affecting children and families’ daily lives. New publication of our large clinical trial show 78.7% children with obesity achieved at least 10% BMI reduction and most moved to lower BMI categories with one of our treatments. Learn more in the press release here: https://www.novonordisk.com/news-and-media/latest-news.html

来源:Novo Nordisk · x.com